"10.1371_journal.pone.0046846","plos one","2012-10-17T00:00:00Z","Lian Shan; Y Ann Chen; Lorelei Davis; Gang Han; Weiwei Zhu; Ashley D Molina; Hector Arango; James P LaPolla; Mitchell S Hoffman; Thomas Sellers; Tyler Kirby; Santo V Nicosia; Rebecca Sutphen","Frantz Biomarkers, LLC, Mentor, Ohio, United States of America; Biostatistics, Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America; Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America; West Coast Gynecologic Oncology, Clearwater, Florida, United States of America; Womens Cancer Associates, Gynecologic Oncology, St. Petersburg, Florida, United States of America; Gynecologic Oncology, College of Medicine, University of South Florida, Tampa, Florida, United States of America; Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America; Department of Pathology and Cell Biology, College of Medicine, University of South Florida, Tampa, Florida, United States of America","Conceived and designed the experiments: RS LS YAC LD GH WZ ADM HA JPL MSH TS TK SVN. Performed the experiments: LS LD YAC GH WZ SVN RS. Analyzed the data: YAC GH WZ SVN RS. Contributed reagents/materials/analysis tools: LS YAC LD GH WZ SVN RS. Wrote the paper: LS YAC LD GH WZ ADM HA JPL MSH TS TK SVN RS.","The authors have read the journals policy and have the following conflicts: 1) Authors and affiliated institutions hold patents on the phospholipids analyzed for this publication and 2) One or more authors are employed by a commercial company. The following patents were filed as a result of the research performed: Method For Detecting Cancer Using LPA as a Marker, Serial #61/189,495, File Date 08/20/08. Licensed 01/09; Method For Detecting Cancer Using Plasmalogens as Markers, Serial #61/199,565, File Date 11/18/08. Licensed 01/09; Method For Detecting Or Monitoring Cancer Using LPC As A Marker (LPC 14âˆ¶0), PCT/US2008/012483, File Date 11/05/08. Licensed 01/09; Lysophosphatidylcholine as a Biomarker of Ovarian Cancer, Patent # US6248553 B1, Filing Date 5/13/05. At the time this research was performed and the manuscript was written two co-authors, Lain Shan and Lorelei Davis, were employed by a commercial company by the name of Frantz Biomarkers, LLC. Frantz Biomarkers, LLC is no longer an operating commercial company. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Lian Shan","LS",13,TRUE,13,7,5,13,TRUE,FALSE,FALSE,0,NA,FALSE
